Embody vs MEDVi: Which GLP-1 Provider Is Better?
Short answer: Embody and MEDVi tie at 7.3/10 on our rubric, so the decision comes down to price and format rather than overall quality. Full reasoning, pricing and the cases where the other one wins are below.
Embody publishes the lower starting rates in this matchup: compounded injections from $69/mo and GLP-1 + GIP injections from $129/mo on selected multi-week plans, compared with MEDVi's $179 semaglutide first month and $299 refill rate. MEDVi offers more formats and has the higher Trustpilot rating at 4.4/5, but both companies have F ratings at the BBB and MEDVi received FDA warning letter #721455.
Disclosure: Embody and MEDVi both pay us a commission when you sign up through our links. Neither commission changes the prices, customer records, FDA record or which provider wins a section below. How we make money.
A side-by-side look at Embody and MEDVi to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Embody
#28 of 54Online weight-loss program that ships compounded GLP-1 medication to your door. Modern Metabolic Medicine, Inc. runs the storefront and OpenLoop Health supplies the clinical network on the current site. Embody now advertises compounded semaglutide from $79 and GLP-1 + GIP from $129; its FAQ says the chosen rate holds within a selected 4-, 12-, 24- or 52-week plan.
Visit EmbodyMEDVi
#42 of 54MEDVi offers a weekly compounded GLP-1 injection and a daily compounded tablet. The injection is $179 for month one and $299 for refills. Trustpilot is 4.3 out of 5 across 14,680 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.
Visit MEDVi| Feature | Embody | MEDVi |
|---|---|---|
| Why each one | Publishes a complete four-tier price ladder for both molecules, so the commitment behind every advertised rate is checkable rather than implied. | A daily dissolvable GLP-1 tablet and a weekly compounded injection in one program, plus brand-name Wegovy and Zepbound on a $99 membership. |
| Our Score | 7.3/10 | 5.7/10 |
| Headline Price | from $69/mo | $179 first month, then $299/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | People comfortable committing to a term, since Embody's cheapest rates are its twelve-month plans, and who want the commitment stated up front rather than implied | Users who want both oral and injectable compounded options in one telehealth program |
| Watch out for | Everything you pay is non-refundable. Embody's refund policy, dated August 25, 2026, says all payments are final at the time of purchase, that cancelling stops future billing only, and that multi-month plans are non-refundable in whole and in part, so the twelve-month plan commits $828 up front and cancellations have to reach support at least 72 hours before the next billing date. | FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication |
| Ranking | #28 | #42 |
| Get started | Visit Embody | Visit MEDVi |
Pros & Cons Compared
Embody
Pros
- +Publishes a complete price ladder for both molecules, so what each advertised rate costs up front is checkable: semaglutide $79/$76/$73/$69 and tirzepatide $129/$126/$123/$119 across one, three, six and twelve months.
- +Advertised injection floors of $79 for semaglutide and $129 for GLP-1 + GIP, verified August 14, 2026. The FAQ says the selected rate holds within the chosen plan.
- +Four plan lengths are disclosed (4, 12, 24 and 52 weeks), giving shoppers a shorter-term option as well as longer-plan pricing.
- +Publishes its cancellation and refund terms in full, dated August 25, 2026, so the 72-hour cancellation cutoff and the all-sales-final rule are readable before you pay.
- +Replies to every negative Trustpilot review, usually within 24 hours.
Cons
- −Everything you pay is non-refundable. Embody's refund policy, dated August 25, 2026, says all payments are final at the time of purchase, that cancelling stops future billing only, and that multi-month plans are non-refundable in whole and in part, so the twelve-month plan commits $828 up front and cancellations have to reach support at least 72 hours before the next billing date.
- −The $79/$129 figures are advertised floors tied to a selected 4-, 12-, 24- or 52-week plan, not a verified no-commitment month-to-month rate. Confirm the plan length and total before payment.
- −Trustpilot rating is 3.7 / 5 across 6,825 reviews, checked 2026-09-03, while the landing page advertises 4.8. Price and billing remain recurring complaint themes, although many reviews describe earlier pricing structures.
- −Embody names four partner pharmacies: Red Rock Compounding Pharmacy in Utah, Health Warehouse in Kentucky, Precision Medicine in New York and Triad Rx in Alabama, and says all four are 503A compounding pharmacies. It does not say which one will fill your prescription. Triad Rx received a 2019 FDA warning letter for sterile-production violations, and the FDA close-out in May 2023 records that the firm no longer produces sterile drug products.
- −Compounded medications only, no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
- −Modern Metabolic Medicine, Inc. also runs SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com). Each footer names the shared parent, but none of the three names the others, and SnagRx sells the same compounded semaglutide and tirzepatide at the same $69 and $119 prices Embody's own landing page shows. See our [SnagRx review](/reviews/snagrx)
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +The landing page says the program is HSA and FSA eligible and includes dietician visits and care coaching, with a footnote making that subject to insurance and copay eligibility
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179 covers the first month of compounded semaglutide on MEDVi's landing page, including physician review, the personalized plan, medication and free shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.3 out of 5 across 14,680 Trustpilot reviews with 12 percent of them at one star, against an F and no accreditation at the BBB
- −The $179 semaglutide price covers month one only; the FAQ on MEDVi's own landing page says refills are locked in at $299 a month, making the first year $3,468 rather than $2,148
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus a medication cost the page does not publish, and the same page's hero says "No membership or hidden fees!" directly above those cards; availability is subject to change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Where Embody wins on price
Embody advertises compounded injections from $69/mo and GLP-1 + GIP injections from $129/mo. Its FAQ ties the rate to a selected 4-, 12-, 24- or 52-week plan, so those are plan-dependent starting prices rather than proof of a flat, no-commitment monthly rate. MEDVi's current Katalys destination lists compounded semaglutide at $179 for month one and $299 for refills. Embody therefore publishes the lower floor, but a defensible total requires the exact medication and plan term at checkout.
The trade-off is choice. Embody's menu is compounded semaglutide, compounded tirzepatide and oral tirzepatide gum. MEDVi lists oral and injectable compounded formats plus brand-name Wegovy, Zepbound and Ozempic paths, although the current landing does not publish an all-in medication cost for those brand options.
Sources: Current Embody offer (affiliate link) · Current MEDVi offer (affiliate link)
Where MEDVi wins on formats and customer ratings
MEDVi offers more ways to take treatment. It lists oral tablets and injections for compounded GLP-1 care, while Embody's unusual non-injection option is tirzepatide gum. Both now name pharmacy partners: MEDVi lists RedRock Pharmacy and Beaker Pharmacy & Compounding; Embody lists RedRock, Health Warehouse, Precision Compounding and Triad Rx.
MEDVi's verified Trustpilot signal is stronger: 4.4/5 across roughly 11,000 reviews against Embody's 3.7/5 across 6,825 on September 3, 2026. Do not read either number alone. Both businesses have unaccredited F ratings at the BBB; Embody's operator had 23 complaints recorded as unanswered, while its older Trustpilot complaints often describe promotional pricing that differs from the current plan-dependent offer.
Sources: MEDVi on Trustpilot · MEDVi at the BBB · Embody on Trustpilot
What the FDA record changes
The FDA issued warning letter #721455 to MEDVi on February 20, 2026. The agency says MEDVi-branded labels implied MEDVi compounded the products when it did not, and that website comparisons implied compounded semaglutide and tirzepatide were equivalent to or FDA-evaluated like approved brands. This is a misbranding and marketing action, not an allegation that the medication was unsafe.
Our published rubric applies the same 2.0-point penalty when an FDA warning letter has no public close-out record. No public close-out letter for MEDVi was found as of August 14, 2026, so MEDVi moves from its 7.7 base score to 5.7. MEDVi gets no scoring exception because it is an affiliate partner.
Sources: FDA warning letter #721455 · Our scoring methodology
Embody vs MEDVi: common questions
Is Embody or MEDVi cheaper?
Embody publishes the lower starting rates: compounded injections from $69/mo and GLP-1 + GIP injections from $129/mo, compared with MEDVi's $179 semaglutide first month and $299 refills. Embody ties its advertised rates to a selected plan length, so compare the exact medication and commitment at checkout rather than treating either floor as a universal annual total.
Does Embody or MEDVi have better reviews?
MEDVi has the higher verified Trustpilot rating, 4.4/5 across roughly 11,000 reviews versus Embody at 3.7/5 across 6,825 on September 3, 2026. Both have F, non-accredited BBB profiles, so the honest answer is that their review and complaint signals are mixed rather than clean endorsements.
Is Embody or MEDVi safer?
We cannot prove one provider's medication is safer from public records alone. We can compare the regulatory and disclosure record: MEDVi received FDA warning letter #721455 for misleading labeling and marketing, while no FDA warning letter is recorded for Embody in our current safety database. The MEDVi letter does not allege unsafe medication. MEDVi names two pharmacy partners and Embody names four; neither disclosure proves medication quality by itself.
Should I choose Embody or MEDVi?
Consider Embody first if the lower advertised plan rate fits your medication and commitment. Consider MEDVi if you specifically need its oral tablet formats or brand-name paths and are comfortable with the $179-to-$299 price step, BBB F and FDA warning record. Both pay us a commission, so affiliate status does not break the tie.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Embody and MEDVi.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Embody and GobyMedsfrom $99/mo
- Compare Embody and WeightWatchers (Sequence)$74/mo membership + medication
- Compare Embody and Novifrom $88/mo
- Compare MEDVi and PeterMDfrom $149/mo
- Compare MEDVi and Oak Longevityfrom $167/mo
- Compare MEDVi and Bodybuilding Health+$179/mo month-to-month
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Embody legit and is MEDVi legit, with the verification evidence behind each answer.